Trump Goes After Venezuela’s Oil

This week, The Daily is revisiting some of our favorite episodes of the year and checking in on what has happened in the time since. In the past few years, GLP-1 weight-loss drugs like Ozempic and Zepbound have been radically reshaping the people’s lives, changing appetites and health. But the drugs also have the power to affect other parts of consumers’ lives, including their romantic relationships. Lisa Miller, who writes about health for The New York Times, tells the story of how these drugs upended one couple’s marriage.

The latest release of files related to the sex offender Jeffrey Epstein left key questions unanswered about his rise to power and his connections to the president. David Enrich, an investigations editor at The New York Times, explains how he worked with a team of reporters to fill in those mysteries and reveal the truth about Mr. Epstein’s origins.

The construction of a giant factory complex in Arizona was supposed to embody the Trump administration’s ability to bring manufacturing back to the United States. But undertaking big projects is not as simple as it seems. Peter S. Goodman, who writes about the intersection of economics and geopolitics for The New York Times, explains why.

In these final weeks of 2025, The Sunday Special is looking back at the year in culture. Today, we’re talking about the TV we watched this year — the best shows, the most popular ones and the ones that allowed us to just enjoyably veg out. Gilbert Cruz talks with the TV critic James Poniewozik and the culture reporter Alexis Soloski about the year in television. TV shows discussed in this episode: “Severance” “Common Side Effects” “Too Much” “Nobody Wants This” “Dying for Sex” “The Hunting Wives” “The White Lotus” “Dr. Odyssey” “Long Story Short” “Heated Rivalry” “Andor” “The Lowdown” “Platonic” “Pluribus” “The Pitt” “Adolescence”

The writer and lawyer has been documenting the occupation for decades. Somehow, he maintains hope.